Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Coloplast DialogueStudy
This study is currently recruiting participants.
Verified by Coloplast A/S, April 2008
Sponsored by: Coloplast A/S
Information provided by: Coloplast A/S
ClinicalTrials.gov Identifier: NCT00626821
  Purpose

The main purpose of the study is to document real life experience on SenSura with focus on skin condition and quality of life.


Condition Intervention Phase
Ostomy
Device: SenSura
Phase IV

MedlinePlus related topics: Ostomy Skin Conditions
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Single Group Assignment, Efficacy Study
Official Title: An Open Label, Non-Comparative, Multi-National Post-Market Study to Document Real Life Experience on SenSura With Focus on Skin Condition and Quality of Life

Further study details as provided by Coloplast A/S:

Primary Outcome Measures:
  • Quality of Life [ Time Frame: week 0 and week 6 ] [ Designated as safety issue: No ]

Estimated Enrollment: 5000
Study Start Date: February 2008
Estimated Study Completion Date: January 2010
Estimated Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental Device: SenSura
Real life assessment of SenSura

Detailed Description:

It is important to continuously develop and test ostomy products in order to prevent peristomal skin disorders and to enhance the quality of life for people with a stoma. Furthermore, it is essential to create awareness about the importance of healthy peristomal skin as many of these conditions are preventable.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • People with an ostomy
  • Subject 18 years of age or older

Exclusion Criteria:

  • Pregnant or breastfeeding women
  • People with more than one ostomy
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00626821

Contacts
Contact: Rikke Agerselv, MSc +45 49 11 17 63 dkrh@coloplast.com

Locations
United States, Missouri
Restored Images Recruiting
Kansas City, Missouri, United States, 64119
Contact: Rebecca Wills, CWOCN     816-454-2900     becky@restoredimages.com    
Principal Investigator: Rebecca Wills, CWOCN            
Sponsors and Collaborators
Coloplast A/S
Investigators
Principal Investigator: Birgitte D Andersen, RN Herlev Hospital, Dep of colorectal surgery
  More Information

Responsible Party: Coloplast A/S ( Erik Andersen/Clinical Trial Manager )
Study ID Numbers: DK175OS
Study First Received: February 21, 2008
Last Updated: April 4, 2008
ClinicalTrials.gov Identifier: NCT00626821  
Health Authority: Denmark: Danish Dataprotection Agency;   Denmark: Ethics Committee;   United States: Institutional Review Board

Study placed in the following topic categories:
Skin Diseases
Quality of Life

ClinicalTrials.gov processed this record on January 16, 2009